Anti-inflammatory and antinociceptive activities of methanolic extract from red seaweed Dichotomaria obtusata by García Delgado, Neivys et al.
*Correspondence: N. G. Delgado. Department of Pharmacology, Center 
of Marine Bioproducts (CEBIMAR), AMA, CITMA. Loma y 37, Al-
turas del Vedado, Plaza de la Revolución, 10400 - Havana, Cuba. E-mail: 
neivys@cebimar.cu; neivysgd8684@gmail.com
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 49, n. 1, jan./mar., 2013
Anti-inflammatory and antinociceptive activities of methanolic 
extract from red seaweed Dichotomaria obtusata
Neivys García Delgado1,*, Ana Iris Frías Vázquez2, Hiran Cabrera Sánchez3, Roberto Menéndez 
Soto del Valle1, Yusvel Sierra Gómez4, Ana María Suárez Alfonso5
1Department of Pharmacology, Center of Marine Bioproducts (CEBIMAR), Havana, Cuba, 2Department of Human and Animal 
Biology, Faculty of Biology, University of Havana, Cuba, 3Pharmacology Central Laboratory, Faculty of Medical Sciences 
Dr. Salvador Allende, Havana, Cuba, 4Center for Protein Studies, Faculty of Biology, University of Havana, Cuba, 5Center of 
Marine Researches, University of Havana, Cuba
The aim of the present work was to investigate the anti-inflammatory and antinociceptive effects of 
methanolic extract from D. obtusata using classic models in mice (croton oil-induced ear edema and 
acetic acid-induced writhing) and a phospholipase A2 activity test. Qualitative analysis of the chemical 
composition of seaweed was also determined by extraction with solvents of increasing polarity and 
precipitation and color tests. Results of qualitative chemical study showed the presence of lactonic and 
phenolic compounds, reduced carbohydrates, other sugars, flavonoids, fatty compounds, triterpenes and 
steroids. The extract inhibited mouse ear edema in a dose-dependent manner with an efficacy higher than 
90% and a mean effective dose of 4.87μg/ear, while intraperitoneal administration presented a moderate 
activity. The extract did not inhibit phospholipase A2 activity. In the writhing test, the intraperitoneal 
administration of the extract showed a strong antinociceptive activity (80.2%), while the oral route showed 
a lower efficacy. In conclusion, this study demonstrated the anti-inflammatory and antinociceptive effects 
of methanol extract of D. obtusata in experimental models, suggesting its therapeutic potential in the 
treatment of peripheral painful and/or inflammatory pathologies.
Uniterms: Dichotomaria obtusata/pharmacognosy. Dichotomaria obtusata/anti-inflammatory activity. 
Dichotomaria obtusata/antinociceptive activity. Mouse ear edema test. Writhing test.
O objetivo do presente trabalho foi investigar os efeitos antiinflamatórios e antinociceptivos de um 
extrato metanólico de D. obtusata, utilizando modelos clássicos em ratos (teste do edema de orelha 
induzido por óleo de cróton e teste de contorções induzidas por ácido acético) e um teste de atividade de 
fosfolipase A2. A análise qualitativa da composição química das algas foi também determinada através 
de extração com solventes de polaridade crescente e testes de precipitação e cor. Os resultados do estudo 
de química qualitativa mostraram a presença de compostos lactônicos e fenólicos, hidratos de carbono 
reduzidos e outros açúcares, flavonoides, compostos graxos, triterpenos e esteroides. O extrato inibiu o 
edema de orelha dos ratos de um modo dependente da dose com eficácia superior a 90% e dose média 
efetiva de 4.87μg/orelha, enquanto a administração intraperitoneal apresentou atividade moderada. O 
extrato não inibiu a atividade da fosfolipase A2. No teste de contorção, a administração intraperitoneal 
do extrato mostrou forte atividade antinociceptiva (80,2%), enquanto a administração oral mostrou 
menor eficácia. Em conclusão, este estudo demonstrou os efeitos antiinflamatórios e antinociceptivos 
do extrato metanólico de D. obtusata em modelos experimentais, sugerindo seu potencial terapêutico 
no tratamento de patologias dolorosas periféricas e/ou inflamatórias.
Unitermos: Dichotomaria obtusata/farmacognosia. Dichotomaria obtusata/atividade antiinflamatória. 
Dichotomaria obtusata/atividade antinociceptiva. Teste do edema de orelha. Teste de contorções.
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INTRODUCTION
Marine environment may contain over 80% of 
world’s species of plants and animals (Kumar, Xi-rong, 
2004). Particularly, seaweeds have been of great interest 
for humans as marine food sources since old times (Ni-
sizawa et al., 1987). Nowadays, these organisms represent 
a promising source of useful products awaiting discovery 
for the prevention or treatment of several pathologies 
(Faulkner, 2002). Ecological pressures, including fight for 
space and predation, have contributed to the evolution of 
secondary metabolites with diverse pharmacological prop-
erties. In fact, the discovery of metabolites with biological 
activities from seaweeds has increased significantly in the 
past three decades (Smit, 2004).
On the other hand, inflammation is a defensive re-
action of organisms to antigenic stimulation or physical 
injuries. This response involves the activation of complex 
metabolic pathways and the intervention of chemical and 
cellular mediators (Pruzanskim, Vadas, 1991; Abbas et al., 
2008). Nevertheless, an exacerbated response can conduce 
to the development of multiple pathologies, including 
rheumatoid arthritis, acute gout, asthma, neurodegenera-
tive diseases and cancer (Kazłowska et al., 2010). Further-
more, pain is a classic sign of this inflammatory response 
(Flórez, Reig, 1994).
Pharmaceutical anti-inflammatory drugs are gener-
ally used to treat inflammation and pain. In general, these 
drugs reduce inflammatory response by suppressing the 
production of pro-inflammatory mediators, which are 
involved in the pathogenesis of inflammatory diseases 
(Guslandi, 1998). Nevertheless, reports on the increased 
risk of digestive, cardiovascular and renal diseases with 
long-term use of several non-steroidal anti-inflammatory 
drugs and the serious systemic side effects of glucocor-
ticoids, have raised concerns about using the drugs (Jug-
dutt, 2007). To overcome this limitation, a considerable 
amount of researches have promoted the discovery and 
development of new bioactive natural products with anti-
inflammatory and antinociceptive properties which do not 
show any side effects.
An increasing number of studies have demonstrated 
that certain extracts and compounds from seaweeds have 
potential anti-inflammatory uses. For example, Ganovski 
et al. in 1979 reported the anti-inflammatory effect of an 
aqueous extract from Cystosina barbata, Ulva lactuca and 
Zostera nona. Also, Payá et al. in 1993 studied the anti-
inflammatory potential of methanol and dichloromethane 
extracts of seven species of seaweeds. A group of inhibitors 
of phospholipase A2 were isolated from different microalgae 
(Mayer et al., 1993). Recently, other metabolites with anti-
inflammatory activity have been obtained from seaweeds, 
including a glycosterol (Awad, 2000), a phlorotannin (Sugi-
ura et al., 2006), polyphenols (Jung et al., 2009; El Gamal, 
2010) and polysaccharides (Ananthi et al., 2010). Moreover, 
various seaweeds have antinociceptive properties (Anca et 
al., 1993; Guzmán et al., 2001; Viana et al., 2002).
Dichotomaria obtusata (J. Ellis, Solander) Lamarck, 
a red seaweed found in tropical and subtropical shores, is 
one of the most common species of the phylum Rhodophyta 
(Suárez, 2005). This species has been used in a small 
number of biological studies. We have recently reported 
the intraperitoneal anti-inflammatory and antinociceptive 
properties of aqueous extract of D. obtusata in two classic 
animal models (Frías et al., 2011). However, anti-inflam-
matory efficacy of the aqueous extract was limited and the 
mechanisms of action have not been examined yet. In order 
to obtain a greater efficacy, a new extract of this seaweed 
was prepared. Therefore, the aim of the current study was to 
evaluate the anti-inflammatory and antinociceptive potential 
of methanolic extract of D. obtusata employing different 
routes of administration. Before that, we have carried out 
a preliminary acute toxicological study of our extract with 
the purpose of knowing the safety of the working material. 
Also, one of the possible mechanisms of action of bioactive 
components of the extract was investigated in an in vitro 
assay. We present novel anti-inflammatory and antinocicep-
tive activities of red seaweed D. obtusata.
MATERIALS AND METHODS
Drugs and reagents
Tested drugs (indomethacin, dexamethasone, ace-
tylsalicylic acid) and reagent (croton oil) were purchased 
from Sigma Chemicals.
Material
The red alga Dichotomaria obtusata was collected 
at Jaimanitas Beach, Havana, in November 2008, and 
was identified by Dr. Ana María Suarez, researcher of the 
Center of Marine Researches, University of Havana. A 
voucher specimen was deposited at the Herbarium from 
Center of Marine Researches under the acquisition number 
r-189. Specimens were washed with common water, dried 
at room temperature and kept at 4 °C until the obtaining 
of the methanolic extract.
Compositional analysis of D. obtusata
The qualitative analysis of the chemical composition 
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of D. obtusata was conducted according to Chabra’s meth-
od (Chabra et al., 1984), which is based on extraction with 
solvents of increasing polarity (dichloromethane, ethanol 
and water) and tests of precipita tion and color solutions.
Preparation of the methanolic extract
Specimens of D. obtusata (50 g) were dissolved 
in 500 mL of methanol and soaked at room temperature 
during 8 hours. The methanol extract was concentrated in 
a rotary evaporator (BUCHI, Model B48C) and stored at 
4 °C until its use.
Animals
All animal experiments were conducted according 
to the Guide for the Care and Use of Laboratory Animals 
of the Center for Laboratory Animals Production (CEN-
PALAB), Cuba. For one week before the experiments, 
male Cenpalab mice: OF-1 weighing 23-25 g were main-
tained in ventilated plastic cages in a soundproofed room 
at 22 °C, with an artificial 12:12 h light:dark cycle. Food 
and sterile water were supplied ad libitum. Animals were 
randomized into treatment groups and deprived of food 
and water during the experiment.
Acute Toxicity Study
The acute toxicity study of the methanolic extract 
of D. obtusata was carried out according to the acute-
toxic-class method as alternative to the LD50 test (Schlede 
et al., 1992). Graded doses (25, 200 and 2000 mg/kg) of 
methanolic extract were administered intraperitoneally to 
various groups, each group containing six mice. On the 
first hour after administration, the animals were evaluated 
every 10 minutes for any changes in respiratory frequency, 
writhing, piloerection, spontaneous motor activity, etc. 
Animals were observed up to 24 hours for any mortality.
Mouse ear edema test
All procedures of mouse ear edema bioassay were 
carried out following the established method of Tubaro et 
al. (1986). Edema was induced in right ear of each mouse 
by the topical application, to both the inner and outer sur-
faces, of 10 µL of a 0.47% croton oil solution in acetone 
to induce inflammation, and the same volume of acetone 
was applied to the left ear. Methanolic extract dissolved 
in ethanol was administered topically (0.5 x 10-3, 1 x 10-3, 
1.5 x 10-3, 7.5 x 10-3, 15 x 10-3, 30 x 10-3, 0.5, 1 and 2 mg/ear) 
and intraperitoneally (i.p.) (12.5, 25, 50 and 100 mg/kg) 
simultaneously and 30 min before croton oil applica-
tion, respectively. As positive controls for comparative 
purposes, other groups of animals were treated with in-
domethacin (0.5 mg/ear and 10 mg/kg) dissolved in 5% 
NaHCO3 and dexamethasone (0.1 mg/ear and 0.5 mg/kg), 
following the same conditions of extract administration. 
Five hours after croton oil application, the animals were 
sacrificed by cervical dislocation and the ears were cut off. 
In all experiments, a disk was cut from the middle part of 
each ear using a punch 7 mm in diameter. The edema size 
was determined in relation to the weight of untreated left 
ear and percentage of inhibition was calculated using the 
following expression:
% Inhibition = (ΔPc - ΔPt)/100 x ΔPc
where: ΔPc → mean weight variation in the control group; 
ΔPt → mean weight variation in the treated group.
Phospholipase A2 activity test
The ability of methanolic extract to inhibit phospho-
lipase A2 was evaluated according to the indirect radial 
hemolysis in agar plate method proposed by Gutiérrez 
et al., in 1988. A Petri plate was prepared with agar con-
taining egg yolks (substrate of phospholipids), calcium 
chloride (enzymatic cofactor), sodium azide (preserva-
tive) and human erythrocytes for visualizing the effect. 
Methanolic extract (2.5, 5 and 10 mg/mL) was dissolved 
in PBS (0.12 M NaCl, 0.04 M NaHPO42-, pH 7.2) and ap-
plied by triplicate in the holes (6-mm diameter) made in 
the plate. The phospholipase A2 purified from sea anemone 
Condylactis gigantea was used as control. This enzyme 
was donated by the Center for Protein Studies, University 
of Havana. The plate was maintained at 37 ºC by 12 hours. 
The enzymatic activity was determined by the presence of 
halos as an indicative of hemolysis.
Acetic acid-induced writhing test
The acetic acid-induced writhing test was conducted 
as originally described by Koster et al in 1959. Mice were 
randomly distributed in control and test groups of ten 
animals each. In this test, an intraperitoneal injection of 
acetic acid (0.8%, 10 ml/kg b.w.) was given 30 and 60 min 
after the i.p. (12.5, 25, 50 and 100 mg/kg) and oral (100, 
200, 400 and 800 mg/kg) administrations of test extract, 
respectively. Also, the reference drug acetylsalicylic acid 
(68 mg/kg) was administrated by oral route 1 hour before 
acetic acid injection, and control group was treated with 
sterile 0.9% saline solution. Following that, the number of 
N. G. Delgado, A. I. F. Vázquez, H. C. Sánchez, R. M. S. del Valle, Y. S. Gómez, A. M. S. Alfonso68
writhing movements in the mice was counted for 20 min. 
The antinociceptive activity of the methanolic extract was 
expressed as percentage of pain reduction in treated mice 
with respect to control, according to the relation:
% Reduction = (ΔCc - ΔCt)/100 x ΔCc
where: ΔCc → mean of number of writhes of control group 
(vehicle-injected animals); ΔCt → mean of number of 
writhes in the treated group.
Statistical analysis
Data are expressed as mean ± SEM. One way analy-
sis of variance (ANOVA) was applied for the analysis of 
results using software packages Statistica (version 7.0) 
and Past (version 1.99). P-values less than 0.05 and 0.001 
were considered significantly different for Tukey-Kramer 
and Bonferroni multiple comparison tests, respectively.
RESULTS
Compositional analysis of D. obtusata
The results of the qualitative chemical study of D. 
obtusata (Table I) showed the notable presence of lactonic 
and phenolic compounds, reduced carbohydrates and other 
sugars. However, the presence of flavonoids, fatty com-
pounds, triterpenes and steroids was low.
Acute Toxicity Study
Acute toxicity results of the intraperitoneal adminis-
tration of methanolic extract are presented in Table II. As 
can be appreciated, no mortality of animals was observed 
after 24 hours of administration of extract at 25, 200 and 
2000 mg/kg. The most significant signs of toxicity were 
swing and writhing, which were presented at all doses. 
Swing showed a percentage of appearance superior at 
65%. Also, the periods of latency of appearance of these 
signs were dose-dependent at doses of 25 and 200 mg/kg. 
However, this parameter decreased at 2000 mg/kg. In 
addition, the stoop of back train was observed at doses of 
200 mg/kg (33.3%) and 2000 mg/kg (66.7%). Finally, a 
sedative effect (33.3% of appearance and 75 sec of latency) 
and the increase of respiratory frequency (100% of ap-
pearance and 56 sec of latency) were observed in animals 
administered with the maximum dose of extract.
Croton oil-induced ear edema test
Table III shows the anti-inflammatory effect of 
TABLE I - Qualitative phytochemical analysis of Dichotomaria obtusata
Test
Extracts
Dichloromethane Ethanolic Aqueous
Sudan (Fatty compounds) +   
Dragendorff (Alkaloids) - - -
Baljet (Lactonic compounds) ++ ++ +++
Ferric Hydroxamate (Coumarins) -  -
Borntrager (Quinones)  -  
Liebermann-Burchard (Triterpenes and steroids) + + +
Catechines  -  
Fehling (Reduced carbohydrates)  - +++
Foam (Triterpene and steroid saponins)  +++ -
Ferric chloride (Phenols and tannins)  ++ ++
Ninhydrin (Amino acids)  +  
Shinoda (Flavonoids)  +  
Kedde (Cardiotonic glycosides) - - -
Anthocyanidins (Flavonoids with structure C6-C3-C6)  +  
Mucilages (Polysaccharides)   ++
Resins  -  
Molish (Carbohydrates)  + ++
Legend: – negative reaction; + weak reaction; ++ half reaction; +++strong reaction.
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TABLE II - Percentage of mortality and signs of toxicity observed in OF-1 mice after i.p. administration of methanolic extract from 
D. obtusata (n=6 animals/dose)
Doses (mg/kg) Mortality (%) Signs of Toxicity Appearance of signs (%) Latency (seconds; mean ± SEM)
25 0 Swing 66.7 58,8 ± 12,6
Writhing 83.3 73,2 ± 6,1
200 0 Swing 100 21,8 ± 2,0
Writhing 100 39,2 ± 4,9
Stoop of back train 33.3 45,5 ± 0,5
2000 0 Swing 66.7 27,5 ± 8,0
Writhing 50 51,7 ± 4,4
Stoop of back train 66.7 31,5 ± 5,3
Increase of respiratory 
frequency
100 55,8 ± 17,3
Sedative effect 33.3 75,0 ± 45,0
TABLE III - Effect of topical administration of methanolic extract 
from D. obtusata on croton oil-induced ear edema in mice (n=6 
animals/doses)
Doses (mg/ear)
Edema (mg) 
(mean ± SEM) 
Edema reduction 
(%)
Control 18.25 ± 0.23  
0,5×10-3 18.37 ± 1.03* 0
1×10-3 17.62 ± 0.85** 3.45
1,5×10-3 15.52 ± 0.72** 14.96
7,5×10-3 9.32 ± 0.52** 48.93
0.015 8.05 ± 0.97** 55.89
0.03 5.02 ± 0.60** 72.49
0.5 2.83 ± 0.65** 84.49
1 1.38 ± 0.43** 92.44
2 3.2 ± 0.18** 82.47
Dexamethasone (0.1) 2.17 ± 0.26* 88.11
Indomethacin (0.5) 7.12 ± 0.60* 60.99
* p < 0.0001 compared with control; **p < 0.0001 compared 
with indomethacin and dexamethasone (Bonferroni’s test)
topical administration of methanolic extract (0.5 x 10-3, 
1 x 10-3, 1.5 x 10-3, 7.5 x 10-3, 15 x 10-3, 30 x 10-3, 0.5, 1 
and 2 mg/ear) on croton oil-induced ear edema in mice. 
The ear edema in control group, five hours after croton 
oil application, was 18.25 ± 0.23 mg. All doses of extract 
decreased significantly (p<0.0001) the action of the irritat-
ing agent except the dose of 0.5 x 10-3 mg/ear.
As can be seen, five of the evaluated doses exerted 
a significant inhibition of edema (> 50%). The extract 
at 1 mg/ear showed the greatest inhibition of edema 
(92.44%), which was similar to reference drug dexa-
methasone (88.11% at 0.1 mg/ear) and far superior to 
indomethacin (60.99% at 0.5 mg/ear).
Methanolic extract showed a dose-dependent anti-
inflammatory effect. Figure 1 illustrates the dose-response 
relation of topical application of extract. The behavior 
of curve indicates that the apparent maximum dose is 
1 mg/ear. Also, the Mean Effective Dose (dose inducing 
a 50% edema inhibition, ED50) was calculated, which was 
4.87 µg/ear.
In the same way, the anti-inflammatory activity of 
extract was evaluated using the systemic administration 
(i.p.). The results obtained at different doses of extract 
FIGURE 1 - Dose-response relation of topical application of 
methanolic extract from D. obtusata.
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(12.5, 25, 50 and 100 mg/kg) are shown in Figure 2. All 
groups of treatment were able to decrease significantly 
(p < 0.05) the croton oil-induced ear edema compared to 
control group (which received 0.9% saline solution). Simi-
lar to topical application, the i.p. administration of extract 
inhibited this edema in a dose-dependent manner. The 
maximum inhibition was 67.94% at dose of 100 mg/kg, 
which was not different from response of reference drugs 
indomethacin (57.24%) and dexamethasone (68.41%).
Phospholipase A2 activity test
One of the probable mechanisms of action of anti-
inflammatory compounds is mediated by the inhibition of 
phospholipase activity. For this reason, methanolic extract 
of D. obtusata was tested for a possible inhibitory activity 
of phospholipase A2, using the indirect radial hemolysis 
in agar plate method. The effect of extract (2.5, 5 and 
10 mg/mL) in this assay is shown in Figure 3. The pres-
ence of halos of hemolysis around the holes of the plate, 
where extract and control phospholipase A2 were applied, 
indicates the extract did not inhibit the enzymatic activity. 
Phospholipase A2 hydrolyzes the phospholipids of egg 
yolk, which are liberated into medium as fatty acids and 
glycerophospholipids. After that, the pH of culture me-
dium decreases and this promotes the lysis of erythrocytes 
and the appearance of halos of hemolysis.
Acetic acid-induced writhing test
Antinociceptive activity of methanolic extract was 
examined using writhing test. Intraperitoneal administra-
tion of the extract at the doses of 12.5, 25, 50 or 100 mg/kg 
body weight decreased significantly (p < 0.0001) the 
action of acetic acid used to induce writhes in mice, in 
comparison to the control animals that received only 0.9% 
saline solution.
The effects of i.p.-administered extract were dose-
dependent. There results can be seen in Figure 4. Treat-
ment with 12.5 mg/kg reduced the number of writhes 
in 47.72%, which was further decreased in 80.2% with 
100 mg/kg of the extract. The reference analgesic drug, 
acetylsalicylic acid (68 mg/kg) caused inhibition of 
writhes in 49.49%.
The results of the acetic acid-induced writhing 
responses in mice one hour after oral administration of 
FIGURE 2 - Effect of intraperitoneal administration of methanolic extract from D. obtusata on croton oil-induced ear edema in 
mice (n=6 animals/dose).
FIGURE 3 - Effect of methanolic extract from D. obtusata (10, 
5 and 2.5 mg/mL) on phospholipase A2 activity.
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FIGURE 4 - Effect of intraperitoneal administration of methanol extract from D. obtusata on acetic acid-induced writhing in mice 
(n=10 animals/dose). ASA: ace tylsalicylic acid (reference drug).
FIGURE 5 - Effect of oral administration of methanol extract from D. obtusata on acetic acid-induced writhing in mice (n=10 
animals/dose). ASA: ace tylsalicylic acid (reference drug).
the extract are presented in Figure 5. In this case, only 
the maximum dose of the extract (800 mg/kg) had a 
clear antinociceptive effect, with a significant reduction 
of the number of writhes (p<0.05) compared to control 
animals. The percentage of inhibition of writhes at this 
dose was 30.87%, which was lower than the reference 
drug (53.25%).
DISCUSSION
The purpose of this paper was to evaluate anti-
inflammatory and antinociceptive effects of methanolic 
extract from the red seaweed Dichotomaria obtusata using 
classic models in mice and an in vitro test.
Red seaweeds are considered the most important 
source of many biologically active me tabolites in com-
parison to other algal classes (El Gamal, 2010). As a first 
step toward identifying the major chemical groups present 
in D. obtusata, we have developed a qualitative chemical 
study of its composition. Results showed the presence 
of lactonic and phenolic compounds, flavonoids, fatty 
compounds, triterpenes, steroids, reduced carbohydrates 
and other sugars. In agreement with our results, Frías et 
al. in 2011 demonstrated the presence of carbohydrates, 
proteins, triterpenes and steroids in the aqueous extract 
from D. obtusata. Some of these compounds, such as 
phenols, terpenes, polysaccharides and steroids, have been 
reported to possess anti-inflammatory and antinociceptive 
effects (Silva, Scheuer, 1980; Chong, Parish, 1985; Awad, 
2000; Lucas et al., 2003; Rodríguez et al., 2004; Jung et 
al., 2009).
On the other hand, it is known that the possible thera-
peutic application of a new drug requires the evaluation 
of its preclinical pharmacological activities and studies of 
safety. Taking into account these considerations, we have 
evaluated the lethality of the methanolic extract using an 
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alternative acute toxicity test. The animals intraperitone-
ally administered showed some signs of toxicity (swing 
and writhing) at all tested doses. Other signs appeared at 
the highest dose (increased respiratory frequency and sed-
ative effect). However, the animals in all groups survived, 
signifying the absence of lethality under our experimental 
conditions. This extract was much less toxic than aque-
ous extract from the same seaweed (unpublished data), 
suggesting that the majority of toxic metabolites from D. 
obtusata are of polar nature.
In a first set of pharmacological experiments, we 
investigated the effects of the extract on croton oil-induced 
ear edema using i.p. and topic single administrations. The 
extract dose dependently reduced edema formation and 
showed potency similar to that of reference drugs by topi-
cal route. In fact, its maximum effect was superior to 90% 
and its ID50 value was 4.87 µg/ear. Taking into account that 
the extract is a complex mixture of several components, 
these values indicate its elevated pharmacological efficacy 
and potency.
Topical application of croton oil produced a longer-
lasting edema associated with marked influx of neutrophils 
and predominant formation of LTB4 along with significant 
changes in levels of TXB2. Also, earlier studies have re-
vealed that histamine, serotonin and prostaglandins could 
play a role in the development of edema induced by this 
irritant agent (Gabor; Razga, 1990; Blazso, Gabor, 1994). 
The advantages of this model include its good predictive 
value for screening topical anti-inflammatory activity and 
its sensitivity to both steroidal and non-steroidal drugs. 
Nevertheless, this sensitivity is dependent on the time 
course of the response (Tubaro et al., 1986).
Although the extract intraperitoneally administered 
was able to reduce the croton oil-induced ear edema at all 
evaluated doses, the efficacy was lower than that of topical 
route. Here, bioavailability factor might also be involved, 
because after topical application a large concentration of 
the extract could be available to the target tissues whereas 
this could be limited with the systemic administration. This 
is in agreement with previous studies of our group on the 
aqueous extract of this seaweed, which demonstrated a 
maximum anti-inflammatory activity greater than 65% in 
TPA-induced ear edema in mice (Frías et al., 2011).
The results obtained in this acute inflammation 
model and the topical efficacy of the extract compared to 
dexamethasone suggest an interaction with metabolites 
of the arachidonic acid pathway, mediated mainly by 
phospholipase A2 (PLA2) and cyclooxygenase (COX) 
enzymes (Chen et al., 1994). Thus, the anti-inflammatory 
mechanism of action of the active components of the 
extract would involve PLA2. For this reason we tested 
the ability of the extract to inhibit PLA2 activity by the 
indirect radial hemolysis in agar plate method. However, 
this study showed absence of inhibitory effect on secretor 
PLA2 activity of C. gigantea. These results partially agree 
with previous studies on the inhibitory activity of PLA2 
of various extracts from seaweeds, revealing inhibitory 
activity only in the extract of Dictyota dentata (Llanio et 
al., 1998). In contrast, Mayer, in 1993, isolated 12 com-
pounds from seaweeds with powerful inhibitory activity 
of PLA2 from bee venom. Our results indicate that this 
study must be extended to other secretor PLA2, including 
PLA2 from mammals.
We also investigated the antinociceptive activity of 
the extract in the acetic acid-induced writhing test in mice. 
The abdominal constriction response induced by acetic 
acid has been mainly used as screening tool for the assess-
ment of analgesic or anti-inflammatory properties of new 
agents as well as a typical model for visceral inflammatory 
pain (Tjølsen, Hole, 1997). The local irritation provoked 
by a test agent in the intraperitoneal cavity triggers a 
diversity of mediators, such as bradykinin, substance P 
and prostaglandins, particularly PGI2, as well as some 
cytokines such as IL-1b, TNF-a and IL-8 (Correa et al., 
1996; Ikeda et al., 2001). These mediators activate chemo-
sensitive nociceptors that contribute to the development 
of inflammatory pain.
The methanolic extract inhibited significantly the 
number of writhes suggesting that its antinociceptive ef-
fect could be related to inhibition of mediators released 
in response to acetic acid. Nevertheless, the intraperito-
neal route was more effective than oral at inhibiting this 
response at all evaluated doses (12.5-100 mg/kg), while 
only the maximum oral dose (800 mg/kg) reduced the 
abdominal constrictions. This result may be due to the lim-
ited bioavailability of the active constituents of the extract 
provoked by a poor absorption or the first-pass effect in 
liver. According to the test employed, this antinociceptive 
effect is probably of peripheral origin. We have previously 
demonstrated the antinociceptive activity of aqueous ex-
tract of this seaweed in the same test Frías et al. (2011), 
although in that study we obtained an effect more potent 
using oral administration. Inhibition of number of writhes 
in extracts and components obtained from seaweeds were 
also demonstrated by Guzmán et al. (2001), Viana et al., 
(2002) and Frías et al. (2011).
In conclusion, it can be suggested that the methano-
lic extract from D. obtusata has powerful topical anti-in-
flammatory and antinociceptive activities. These observed 
properties could be associated with a probable synergistic 
effect of the diverse components of methanolic extract. 
Further studies are required to isolate the active principles 
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and to determine the possible mechanism of actions of 
these compounds and their potential for therapeutic use 
in the treatment of inflammatory and pain pathologies.
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